Clinical Evaluation of the Next Generation Venue Ultrasound System, Components, and Accessories - Canada
1 other identifier
interventional
35
1 country
1
Brief Summary
The purpose of the study is to collect images data sets from clinical cases and periodic user feedback on the Next Generation Venue ultrasound system under clinical conditions. This is a medical device study designed as a clinical, open label, unblinded, non-randomized, prospective, feasibility research study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 2, 2017
CompletedFirst Submitted
Initial submission to the registry
January 22, 2018
CompletedFirst Posted
Study publicly available on registry
August 31, 2018
CompletedAugust 31, 2018
August 1, 2018
2 months
January 22, 2018
August 28, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Obtain Image sets using Ultrasound Venue System
Number of representative image sets for subjects enrolled in study
Two months
Periodic user feedback
Periodic user feedback data from device users.
Two months
Study Arms (1)
Eligible Subjects
OTHERAll subjects will be enrolled into a single arm and will undergo an ultrasound exam, per the protocol.
Interventions
Eligible subjects will be positioned for their ultrasound exam, which will take a similar amount of time and be performed in a similar manner as standard of care ultrasound exams at the site. The type and duration of ultrasound exam will be based on the subject's clinical condition.
Eligibility Criteria
You may qualify if:
- Adults (aged 18 years of age or older) at the time of consent;
- Eligible to undergo ultrasound scanning per the site standard of care (with or without a clinical indication for scanning); AND
- Able and willing to provide written informed consent for participation.
You may not qualify if:
- Are pregnant subjects;
- Require procedures that cannot be readily completed using available investigational devices; OR
- Require or are anticipated to require medical care where study participation could reasonably be expected to adversely impact patient care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GE Healthcarelead
Study Sites (1)
Hopital Notre-Dame
Montreal, Quebec, H2L 4M1, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Girard, MD
Hopital Notre-Dame
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2018
First Posted
August 31, 2018
Study Start
June 14, 2017
Primary Completion
August 1, 2017
Study Completion
August 2, 2017
Last Updated
August 31, 2018
Record last verified: 2018-08